Picture of Repare Therapeutics logo

RPTX — Repare Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Repare Issues Statement On Inadvertent Issuance Of Abstract By ANE Conference

Oct 7 (Reuters) - Repare Therapeutics Inc  RPTX.O :
    * REPARE THERAPEUTICS -ISSUES STATEMENT ON INADVERTENT
ISSUANCE OF
ABSTRACT BY AACR-NCI-EORTC VIRTUAL INTERNATIONAL CONFERENCE ON
MOLECULAR TARGETS AND CANCER THERAPEUTICS
    * REPARE THERAPEUTICS - ANE CONFERENCE ISSUED EARLY ABSTRACT
HIGHLIGHTING UPCOMING ORAL PRESENTATION OF INITIAL MONOTHERAPY
CLINICAL DATA FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF RP-3500
    * REPARE THERAPEUTICS INC - ABSTRACT HIGHLIGHTS RESULTS
TAKEN FROM
A VERY EARLY CUTOFF DATE FOR ONGOING STUDY, CURRENTLY IN ITS
PHASE 1 PORTION
    * REPARE THERAPEUTICS - ORAL PRESENTATION, EXPECTED TO TAKE
PLACE
ON OCT 8, TO INCLUDE SIGNIFICANTLY MORE PATIENT DATA, LATER CUT
OFF DATE & CONSEQUENT LONGER FOLLOW UP

Source text for Eikon:  ID:nBw91Bhsma 
Further company coverage:  RPTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Repare Therapeutics

See all news